GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (MEX:AMG N) » Definitions » Shiller PE Ratio

Amgen (MEX:AMG N) Shiller PE Ratio : 21.88 (As of Jul. 22, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Amgen Shiller PE Ratio?

As of today (2025-07-22), Amgen's current share price is MXN5550.00. Amgen's E10 for the quarter that ended in Mar. 2025 was MXN253.65. Amgen's Shiller PE Ratio for today is 21.88.

The historical rank and industry rank for Amgen's Shiller PE Ratio or its related term are showing as below:

MEX:AMG N' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.58   Med: 26.06   Max: 35.25
Current: 24.08

During the past years, Amgen's highest Shiller PE Ratio was 35.25. The lowest was 18.58. And the median was 26.06.

MEX:AMG N's Shiller PE Ratio is ranked better than
56.38% of 525 companies
in the Drug Manufacturers industry
Industry Median: 27.48 vs MEX:AMG N: 24.08

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Amgen's adjusted earnings per share data for the three months ended in Mar. 2025 was MXN65.466. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is MXN253.65 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amgen Shiller PE Ratio Historical Data

The historical data trend for Amgen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amgen Shiller PE Ratio Chart

Amgen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.12 22.55 23.60 24.23 21.55

Amgen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.90 26.39 26.43 21.55 25.35

Competitive Comparison of Amgen's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Amgen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amgen's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amgen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amgen's Shiller PE Ratio falls into.


;
;

Amgen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amgen's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5550.00/253.65
=21.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amgen's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Amgen's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=65.466/134.9266*134.9266
=65.466

Current CPI (Mar. 2025) = 134.9266.

Amgen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 33.734 100.684 45.207
201509 41.231 100.392 55.415
201512 40.752 99.792 55.100
201603 43.035 100.470 57.794
201606 45.679 101.688 60.610
201609 51.819 101.861 68.640
201612 53.398 101.863 70.731
201703 52.533 102.862 68.909
201706 52.601 103.349 68.673
201709 50.088 104.136 64.898
201712 -115.677 104.011 -150.060
201803 59.045 105.290 75.665
201806 68.380 106.317 86.781
201809 53.496 106.507 67.771
201812 59.101 105.998 75.231
201903 61.686 107.251 77.604
201906 68.576 108.070 85.618
201909 64.556 108.329 80.406
201912 53.751 108.420 66.892
202003 71.985 108.902 89.188
202006 70.400 108.767 87.332
202009 75.772 109.815 93.099
202012 54.902 109.897 67.406
202103 57.848 111.754 69.843
202106 16.124 114.631 18.979
202109 68.060 115.734 79.346
202112 68.927 117.630 79.063
202203 53.361 121.301 59.355
202206 49.289 125.017 53.196
202209 80.058 125.227 86.259
202212 58.488 125.222 63.021
202303 95.172 127.348 100.836
202306 44.060 128.729 46.181
202309 56.089 129.860 58.278
202312 24.103 129.419 25.129
202403 -3.485 131.776 -3.568
202406 25.282 132.554 25.735
202409 102.783 133.029 104.249
202412 24.193 133.157 24.514
202503 65.466 134.927 65.466

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amgen  (MEX:AMG N) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Amgen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Amgen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amgen Business Description

Address
One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Headlines

No Headlines